Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gavin Peter Dunn, Ph.D., M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01NS112712 (DUNN, GAVIN PETER) Sep 15, 2019 - Jun 30, 2024
    Targeting Neoantigens in Glioblastoma
    Role: Principal Investigator
  2. K08NS092912 (DUNN, GAVIN PETER) Jul 1, 2015 - Jun 30, 2020
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Dunn GP, Sherpa N, Manyanga J, Johanns TM. Considerations for personalized neoantigen vaccination in Malignant glioma. Adv Drug Deliv Rev. 2022 07; 186:114312. PMID: 35487282.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  2. Mei Y, Bi WL, Agolia J, Hu C, Giantini Larsen AM, Meredith DM, Al Abdulmohsen S, Bale T, Dunn GP, Abedalthagafi M, Dunn IF. Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary. 2021 Jun; 24(3):359-373. PMID: 33492612.
    Citations: 1     Fields:    Translation:Humans
  3. Mei Y, Du Z, Hu C, Greenwald NF, Abedalthagafi M, Agar NYR, Dunn GP, Bi WL, Santagata S, Dunn IF. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017 09 18; 15(1):34. PMID: 28923059; PMCID: PMC5604305.
    Citations: 9     Fields:    Translation:HumansCells
  4. Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, A Ducar M, Thorner AR, van Hummelen P, O Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R. Erratum: Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017; 2:26. PMID: 29263836; PMCID: PMC5677977.
    Citations: 6     
  5. Young GJ, Bi WL, Wu WW, Johanns TM, Dunn GP, Dunn IF. Management of intracranial melanomas in the era of precision medicine. Oncotarget. 2017 Oct 24; 8(51):89326-89347. PMID: 29179523.
    Citations: 6     Fields:    
  6. Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, Dunn IF. Genomic profile of human meningioma cell lines. PLoS One. 2017; 12(5):e0178322. PMID: 28552950.
    Citations: 22     Fields:    Translation:HumansCells
  7. Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, Ducar M, Thorner AR, van Hummelen P, Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R. Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017; 2. PMID: 28713588; PMCID: PMC5506858.
    Citations: 46     
  8. Mei Y, Bi WL, Greenwald NF, Du Z, Agar NY, Kaiser UB, Woodmansee WW, Reardon DA, Freeman GJ, Fecci PE, Laws ER, Santagata S, Dunn GP, Dunn IF. Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016 Nov 22; 7(47):76565-76576. PMID: 27655724.
    Citations: 44     Fields:    Translation:Humans
  9. Campbell AA, Cunnane ME, Dunn GP, Gray ST, Lefebvre DR. Spontaneous Resorption of a Penetrating Orbital Bone Fracture Fragment. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct; 31(5):e123-5. PMID: 24833452.
    Citations:    Fields:    Translation:Humans
  10. Luo LY, Kim E, Cheung HW, Weir BA, Dunn GP, Shen RR, Hahn WC. The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Mol Cancer Res. 2015 Mar; 13(3):502-9. PMID: 25368431; PMCID: PMC4369154.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  11. Dunn GP, Cheung HW, Agarwalla PK, Thomas S, Zektser Y, Karst AM, Boehm JS, Weir BA, Berlin AM, Zou L, Getz G, Liu JF, Hirsch M, Vazquez F, Root DE, Beroukhim R, Drapkin R, Hahn WC. In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene. Proc Natl Acad Sci U S A. 2014 Jan 21; 111(3):1102-7. PMID: 24385586.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  12. Yang JC, Aronson JP, Dunn GP, Codd PJ, Buchbinder BR, Eskandar EN. Three-dimensional brain surface visualization for epilepsy surgery of focal cortical dysplasia. J Clin Neurosci. 2014 Jul; 21(7):1230-2. PMID: 24485033.
    Citations:    Fields:    Translation:Humans
  13. Jones PS, Dunn GP, Barker FG, Curry WT, Hochberg FH, Cahill DP. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium. Neurosurg Focus. 2013 Feb; 34(2):E9. PMID: 23373454.
    Citations: 6     Fields:    Translation:Humans
  14. Dunn GP, Andronesi OC, Cahill DP. From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma. Neurosurg Focus. 2013 Feb; 34(2):E2. PMID: 23373447.
    Citations: 28     Fields:    Translation:HumansAnimals
  15. Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg. 2013 Jan; 118(1):142-8. PMID: 23101443.
    Citations: 20     Fields:    Translation:Humans
  16. Dunn GP, Fecci PE, Curry WT. Cancer immunoediting in malignant glioma. Neurosurgery. 2012 Aug; 71(2):201-22; discussion 222-3. PMID: 22353795.
    Citations: 40     Fields:    Translation:HumansAnimals
  17. Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, Hahn WC. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012 Apr 15; 26(8):756-84. PMID: 22508724.
    Citations: 276     Fields:    Translation:HumansCells
  18. Dunn GP, Nahed BV, Walcott BP, Jung H, Tierney TS, Ogilvy CS. Dual ipsilateral craniotomies through a single incision for the surgical management of multiple intracranial aneurysms. World Neurosurg. 2012 Mar-Apr; 77(3-4):502-6. PMID: 22120339.
    Citations: 3     Fields:    Translation:Humans
  19. Dunn GP, Gerrard JL, Jho DH, Ogilvy CS. Surgical treatment of a large fusiform distal anterior cerebral artery aneurysm with In Situ end-to-side A3-A3 bypass graft and aneurysm trapping: case report and review of the literature. Neurosurgery. 2011 Feb; 68(2):E587-91; discussion E591. PMID: 21135720.
    Citations: 3     Fields:    Translation:Humans
  20. Wiedemeyer WR, Dunn IF, Quayle SN, Zhang J, Chheda MG, Dunn GP, Zhuang L, Rosenbluh J, Chen S, Xiao Y, Shapiro GI, Hahn WC, Chin L. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Proc Natl Acad Sci U S A. 2010 Jun 22; 107(25):11501-6. PMID: 20534551.
    Citations: 113     Fields:    Translation:HumansAnimalsCells
  21. Agarwalla PK, Dunn GP, Laws ER. An historical context of modern principles in the management of intracranial injury from projectiles. Neurosurg Focus. 2010 May; 28(5):E23. PMID: 20568940.
    Citations:    Fields:    Translation:Humans
  22. Uppaluri R, Dunn GP, Lewis JS. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun. 2008 Dec 04; 8:16. PMID: 19053167.
    Citations: 48     Fields:    Translation:HumansAnimalsCells
  23. Dunn GP, Lewis JS, Sunwoo JB, Uppaluri R. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia. Head Neck. 2008 Feb; 30(2):267-72. PMID: 17657794.
    Citations: 4     Fields:    Translation:Humans
  24. Dunn GP, Dunn IF, Curry WT. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun. 2007 Aug 13; 7:12. PMID: 17691714; PMCID: PMC2935751.
    Citations: 69     Fields:    Translation:HumansCells
  25. Dunn IF, Dunn G, Day AL. Neurosurgeons and their contributions to modern-day athletics: Richard C. Schneider Memorial Lecture. Neurosurg Focus. 2006 Oct 15; 21(4):E1. PMID: 17112187.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dunn's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (136)
Co-Authors (36)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.